-
Biotech Stock Alert; (OTCBB: UVFT) Reports Air Purifier Technology Fights Superbugs NDM-1
Monday, September 27, 2010 - 10:41am | 1203Read More...CENTERVILLE, MA--(Investorideas.com newswire, www.biotechindustrystocks.com ) – Biotechnology Company News- UV Flu Technologies, Inc. (OTC.BB:UVFT ) recently announced news that in response to recent outbreaks of drug resistant superbugs such as NDM-1, and persistent occurrences of highly...
-
BioSante Pharmaceuticals (NASDAQ: BPAX), Inc. To Present at the JMP Healthcare Conference
Wednesday, September 22, 2010 - 11:51am | 534Read More...LINCOLNSHIRE, Ill. - September 22, 2010 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) will present at the JMP Healthcare Conference being held in the New York Palace Hotel, New York City from September 27-28, 2010 Phillip B. Donenberg, BioSante's senior vice president...
-
Johnson & Johnson Provides Justification To Stay On The Sidelines
Wednesday, July 21, 2010 - 7:31am | 112Read More...According to Goldman Sachs, Johnson & Johnson (NYSE: JNJ) was highlighted with risk as it headed into it's 2Q due to $0.11 below consensus rating and potential management guidance reduction for 2010 due to cost-restructuring challenges. Goldman has maintained Johnson & Johnson at "neutral...
-
Merck leads drug stocks up
Wednesday, January 13, 2010 - 3:01pm | 199Read More...Shares of pharmaceutical giant Merck & Co. (NYSE: MRK) were up after analysts at Credit Suisse upgraded the stock rating from a neutral to an outperform and raised the target price from $35 to $47. Credit Suisse cited the many promising products in Merck's pipeline. Merck Chief Executive...
